Terms: = Ovarian cancer AND TMPRSS2, PRSS10, 7113, ENSG00000184012, O15393
11 results:
1. Molecular basis and therapeutic targets in prostate cancer: A comprehensive review.
Militaru FC; Militaru V; Crisan N; Bocsan IC; Udrea AA; Catana A; Kutasi E; Militaru MS
Biomol Biomed; 2023 Sep; 23(5):760-771. PubMed ID: 37021836
[TBL] [Abstract] [Full Text] [Related]
2. Multi-omics of the expression and clinical outcomes of tmprss2 in human various cancers: A potential therapeutic target for COVID-19.
Liu L; Qin JF; Zuo MZ; Zhou Q
J Cell Mol Med; 2022 Feb; 26(3):709-724. PubMed ID: 34951103
[TBL] [Abstract] [Full Text] [Related]
3. Novel Case of Isolated Peritoneal Carcinomatosis from Metastatic Prostate cancer Carrying a Pathogenic BRCA Mutation Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
King MC; Sardi A; Velez-Mejia C; Sittig M; Ledakis P
Urology; 2021 Sep; 155():210-213. PubMed ID: 34048828
[TBL] [Abstract] [Full Text] [Related]
4. COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease.
Katopodis P; Kerslake R; Davies J; Randeva HS; Chatha K; Hall M; Spandidos DA; Anikin V; Polychronis A; Robertus JL; Kyrou I; Karteris E
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33649798
[TBL] [Abstract] [Full Text] [Related]
5. Trends in incidence, treatment and survival of borderline ovarian tumors in the Netherlands: a nationwide analysis.
Schuurman MS; Timmermans M; van Gorp T; de Vijver KKV; Kruitwagen RFPM; Lemmens VEPP; van der Aa MA
Acta Oncol; 2019 Jul; 58(7):983-989. PubMed ID: 31135241
[No Abstract] [Full Text] [Related]
6. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
Wu WJ; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
[TBL] [Abstract] [Full Text] [Related]
7. Low frequency of ESRRA-C11orf20 fusion gene in ovarian carcinomas.
Micci F; Panagopoulos I; Thorsen J; Davidson B; Tropé CG; Heim S
PLoS Biol; 2014 Feb; 12(2):e1001784. PubMed ID: 24504521
[TBL] [Abstract] [Full Text] [Related]
8. The oncogenic gene fusion tmprss2: ERG is not a diagnostic or prognostic marker for ovarian cancer.
Huang L; Schauer IG; Zhang J; Mercado-Uribe I; Deavers MT; Huang J; Liu J
Int J Clin Exp Pathol; 2011; 4(7):644-50. PubMed ID: 22076164
[TBL] [Abstract] [Full Text] [Related]
9. Successful pregnancy and normal delivery after whole craniospinal irradiation in two patients.
Shigematsu N; Shinmoto H; Ito N; Kunieda E; Takeda A; Ohashi T; Kawaguchi O; Kawata T; Ito H; Kuribayashi S; Kubo A
Anticancer Res; 2005; 25(5):3481-7. PubMed ID: 16101166
[TBL] [Abstract] [Full Text] [Related]
10. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
[TBL] [Abstract] [Full Text] [Related]
11. Hexamethylmelamine in alkylating agent-resistant ovarian carcinoma.
Johnson BL; Fisher RI; Bender RA; DeVita VT; Chabner BA; Young RC
Cancer; 1978 Nov; 42(5):2157-61. PubMed ID: 102417
[TBL] [Abstract] [Full Text] [Related]
